Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?

Hypogammaglobulinemia (HGG) is a frequent finding in patients with hematological malignancies, and is commonly described in chronic lymphocytic leukemia (CLL) before or after treatment. We reviewed published literature available online in the last thirty years through Medline search of indexed artic...

Descripción completa

Detalles Bibliográficos
Autores principales: Noto, Alessandro, Cassin, Ramona, Mattiello, Veronica, Bortolotti, Marta, Reda, Gianluigi, Barcellini, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140292/
https://www.ncbi.nlm.nih.gov/pubmed/37122737
http://dx.doi.org/10.3389/fimmu.2023.1062376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140292/
https://www.ncbi.nlm.nih.gov/pubmed/37122737
http://dx.doi.org/10.3389/fimmu.2023.1062376

Ejemplares similares